Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tourette's syndrome.

× No keyword cloud information.

65 in total

1. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.

Authors: A J Church; R C Dale; A J Lees; G Giovannoni; M M Robertson
Journal: J Neurol Neurosurg Psychiatry Date: 2003-05 Impact factor: 10.154

2. Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.

Authors: Weidong Ji; Ning Li; Kang Ju; Hong Zheng; Chuang Yang; Ping Xu; Silu Chen; Aiai Cao; Xue Chen; Lanting Guo
Journal: Neurol Sci Date: 2014-11-04 Impact factor: 3.307

Review 3. Botulinum toxin in clinical practice.

Authors: J Jankovic
Journal: J Neurol Neurosurg Psychiatry Date: 2004-07 Impact factor: 10.154

4. Neurosurgical interventions for neuropsychiatric syndromes.

Authors: C Alan Anderson; David B Arciniegas
Journal: Curr Psychiatry Rep Date: 2004-10 Impact factor: 5.285

5. Involvement of immunologic and biochemical mechanisms in the pathogenesis of Tourette's syndrome.

Authors: Yuval Eliahu Landau; Tamar Steinberg; Brian Richmand; James Frederick Leckman; Alan Apter
Journal: J Neural Transm (Vienna) Date: 2011-12-03 Impact factor: 3.575

Review 6. The genetics of Tourette syndrome.

Authors: Hao Deng; Kai Gao; Joseph Jankovic
Journal: Nat Rev Neurol Date: 2012-03-13 Impact factor: 42.937

7. Centromedian-parafascicular deep brain stimulation induces differential functional inhibition of the motor, associative, and limbic circuits in large animals.

Authors: Joo Pyung Kim; Hoon-Ki Min; Emily J Knight; Penelope S Duffy; Osama A Abulseoud; Michael P Marsh; Katherine Kelsey; Charles D Blaha; Kevin E Bennet; Mark A Frye; Kendall H Lee
Journal: Biol Psychiatry Date: 2013-08-30 Impact factor: 13.382

8. ["Hypermetamorphosis". Heinrich Neumann's (1814-1884) legacy].

Authors: A Danek
Journal: Nervenarzt Date: 2007-03 Impact factor: 1.214

9. How relevant are GFAP autoantibodies in autism and Tourette Syndrome?

Authors: Nikki J Kirkman; Jane E Libbey; Thayne L Sweeten; Hilary H Coon; Judith N Miller; Edward K Stevenson; Janet E Lainhart; William M McMahon; Robert S Fujinami
Journal: J Autism Dev Disord Date: 2007-06-20

10. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors: D M Simpson; A Blitzer; A Brashear; C Comella; R Dubinsky; M Hallett; J Jankovic; B Karp; C L Ludlow; J M Miyasaki; M Naumann; Y So
Journal: Neurology Date: 2008-05-06 Impact factor: 9.910